{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:34:08Z","timestamp":1790087648042,"version":"4.0.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ygyno.2016.03.036","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T12:04:16Z","timestamp":1460289856000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["The biological significance and clinical applications of exosomes in ovarian cancer"],"prefix":"10.1016","volume":"142","clinical-trial-number":[{"clinical-trial-number":"nct02063464","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kalpana Deepa Priya","family":"Dorayappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Wallbillich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuppaiyah","family":"Selvendiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.03.036_bb0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1600-0854.2005.00302.x","article-title":"Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells","volume":"6","author":"Nickel","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0010","first-page":"2875","article-title":"Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity","volume":"29","author":"Giuntoli","year":"2009","journal-title":"Anticancer Res."},{"issue":"Suppl. 4","key":"10.1016\/j.ygyno.2016.03.036_bb0015","first-page":"3","article-title":"Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy","author":"Szajnik","year":"2013","journal-title":"Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","article-title":"Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM","volume":"107","author":"Runz","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097580","article-title":"Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells","volume":"9","author":"Dutta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0035","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1007\/s13277-014-2377-z","article-title":"Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein","volume":"35","author":"Lv","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0897.1983.tb00204.x","article-title":"\u201cMembrane-associated\u201d immunoglobulins in cyst and ascites fluids of ovarian cancer patients","volume":"3","author":"Taylor","year":"1983","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2407-11-108","article-title":"Interaction and uptake of exosomes by ovarian cancer cells","volume":"11","author":"Escrevente","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0050","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1074\/mcp.M000063-MCP201","article-title":"Proteomics analysis of bladder cancer exosomes","volume":"9","author":"Welton","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0055","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1158\/0008-5472.CAN-07-0520","article-title":"Tumor-released microvesicles as vehicles of immunosuppression","volume":"67","author":"Valenti","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6602360","article-title":"Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?","volume":"92","author":"Whiteside","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjc.6602316","article-title":"Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects","volume":"92","author":"Taylor","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0075","year":"2015","journal-title":"Ovary Cancer"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fonc.2014.00127","article-title":"Functions and therapeutic roles of exosomes in cancer","volume":"4","author":"Tickner","year":"2014","journal-title":"Front Oncol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0085","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1074\/mcp.M114.041194","article-title":"Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication","volume":"13","author":"Shender","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0090","doi-asserted-by":"crossref","first-page":"701390","DOI":"10.1155\/2015\/701390","article-title":"High LIN28A expressing ovarian cancer cells secrete exosomes that induce invasion and migration in HEK293 cells","volume":"2015","author":"Enriquez","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1582-4934.2011.01316.x","article-title":"Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients","volume":"16","author":"Yin","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0100","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.4161\/cc.8.13.8988","article-title":"Microvesicles: messengers and mediators of tumor progression","volume":"8","author":"Al-Nedawi","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-010-0534-4","article-title":"Survivin is released from cancer cells via exosomes","volume":"16","author":"Khan","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2010.05.010","article-title":"MicroRNA signatures differentiate uterine cancer tumor subtypes","volume":"118","author":"Ratner","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0125","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1101\/gad.1384005","article-title":"A human, ATP-independent, RISC assembly machine fueled by pre-miRNA","volume":"19","author":"Maniataki","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000457","article-title":"Evidence for antisense transcription associated with microRNA target mRNAs in Arabidopsis","volume":"5","author":"Luo","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0135","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0140","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.2174\/092986712800269362","article-title":"Role of microRNAs in gynecological pathology","volume":"19","author":"Gilabert-Estelles","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-62703-453-1_4","article-title":"Analysis of microRNA and protein transfer by exosomes during an immune synapse","volume":"1024","author":"Villarroya-Beltri","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0150","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.celrep.2014.07.035","article-title":"Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells","volume":"8","author":"Squadrito","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jprot.2012.12.029","article-title":"Characterization and proteomic analysis of ovarian cancer-derived exosomes","volume":"80","author":"Liang","year":"2013","journal-title":"J. Proteome"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1479-5876-12-4","article-title":"Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200","volume":"12","author":"Kobayashi","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0165","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/j.1582-4934.2010.01058.x","article-title":"The role of microRNAs in ovarian cancer initiation and progression","volume":"14","author":"Li","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2008.08.017","article-title":"Role of microRNAs in drug-resistant ovarian cancer cells","volume":"111","author":"Sorrentino","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncy.21442","article-title":"Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions","volume":"122","author":"Cappellesso","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0180","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/carcin\/bgu130","article-title":"Exosome-derived miRNAs and ovarian carcinoma progression","volume":"35","author":"Vaksman","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2407-12-421","article-title":"Hypoxic enhancement of exosome release by breast cancer cells","volume":"12","author":"King","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10555-013-9441-9","article-title":"Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review","volume":"32","author":"Azmi","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2008.12.028","article-title":"Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes","volume":"278","author":"Keller","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","article-title":"The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts","volume":"21","author":"Peinado","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0205","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1593\/neo.09822","article-title":"CD44v6 dependence of premetastatic niche preparation by exosomes","volume":"11","author":"Jung","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/mc.22124","article-title":"Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules","volume":"54","author":"Ramteke","year":"2015","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0220","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/ijc.24451","article-title":"Caveolin-1 tumor-promoting role in human melanoma","volume":"125","author":"Felicetti","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0225","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/ncb2574","article-title":"Active Wnt proteins are secreted on exosomes","volume":"14","author":"Gross","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0230","doi-asserted-by":"crossref","first-page":"216","DOI":"10.18632\/oncoscience.26","article-title":"Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor","volume":"1","author":"McCann","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0235","article-title":"Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment","author":"Rauschenberger","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2015.07.014","article-title":"Exosomes: emerging biomarkers and targets for ovarian cancer","volume":"367","author":"Tang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0245","article-title":"Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0250","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymeth.2015.03.009","article-title":"An optimized procedure for exosome isolation and analysis using serum samples: application to cancer biomarker discovery","volume":"87","author":"Li","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0255","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0260","first-page":"36","article-title":"Real-time liquid biopsies become a reality in cancer treatment","volume":"3","author":"Karachaliou","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0265","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2407-9-244","article-title":"Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer","volume":"9","author":"Li","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0270","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","article-title":"Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells","volume":"4","author":"Safaei","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2014.12.042","article-title":"The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells","volume":"137","author":"Pink","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0280","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cam4.409","article-title":"Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells","volume":"4","author":"Weiner-Gorzel","year":"2015","journal-title":"Cancer med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0285","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22773","article-title":"Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy","volume":"227","author":"Ciravolo","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0290","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0295","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/JTO.0b013e31823815d3","article-title":"DeltaNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach","volume":"7","author":"Pelosi","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0300","first-page":"457","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"19\u201330; sup","key":"10.1016\/j.ygyno.2016.03.036_bb0305","first-page":"1","article-title":"Rab27a and Rab27b control different steps of the exosome secretion pathway","volume":"12","author":"Ostrowski","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0310","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1479-5876-10-134","article-title":"Exosome removal as a therapeutic adjuvant in cancer","volume":"10","author":"Marleau","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial","volume":"3","author":"Escudier","year":"2005","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0320","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0325","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/mt.2008.1","article-title":"Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer","volume":"16","author":"Dai","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0330","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1016\/j.vaccine.2011.09.133","article-title":"Increasing vaccine potency through exosome antigen targeting","volume":"29","author":"Hartman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0335","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0340","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1002\/adma.201403562","article-title":"Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer","volume":"26","author":"Tian","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ygyno.2016.03.036_bb0345","first-page":"75","article-title":"A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy","volume":"2014","author":"Johnsen","year":"1846","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ygyno.2016.03.036_bb0350","first-page":"1525","article-title":"Exosome mimetics: a novel class of drug delivery systems","volume":"7","author":"Kooijmans","year":"2012","journal-title":"Int. J. Nanomedicine"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T08:10:21Z","timestamp":1567757421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816300920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0090825816300920"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.036","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biological significance and clinical applications of exosomes in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}